Kymera | Investor Presentation Deck | 60 slides · page 37 of 60
The slide outlines a standard oncology dose-escalation study design (3+3 or similar) followed by expansion cohorts.
Pitch deck · appendix_methodology · plan_implementation · balanced density
Slide locked Sign in to view
Slide schematic 4/4
diagram 1/1 source-note 1/1 table 1/1 title 1/1
Components 4
process source-note data headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1